The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 8, 2012, Pages 1014-1022

  Ohsawa, Y ^a   Hirasawa, N ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Histamine H1 receptor; Histamine H4 receptor; Keratinocytes; Mast cells

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; HISTAMINE H1 RECEPTOR; HISTAMINE H4 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; OLOPATADINE; PREDNISOLONE; SEMAPHORIN 3A; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CHRONIC ALLERGIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; IN VITRO STUDY; INHIBITION KINETICS; KERATINOCYTE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SKIN ALLERGY;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CHEMOKINE CCL17; CHEMOKINE CCL22; CYTOKINES; DERMATITIS, ATOPIC; DIBENZOXEPINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HISTAMINE; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; IMMUNOGLOBULIN E; INDOLES; MALE; MAST CELLS; MICE; PICRYL CHLORIDE; PIPERAZINES; RECEPTORS, HISTAMINE H1; SEMAPHORIN-3A;

EID: 84863845497     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02854.x     Document Type: Article

References (35)

1. Novak N, Bieber T, Leung DY,. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112: S128-S139. (Pubitemid 37550029)
2. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA,. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657. (Pubitemid 38544154)
3. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680. (Pubitemid 34752477)
4. Repka-Ramirez MS, Baraniuk JN,. Histamine in health and disease. Clin Allergy Immunol 2002; 17: 1-25.
5. Paus R, Schmelz M, Biro T, Steinhoff M,. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006; 116: 1174-1185.
6. Heyer G, Dotzer M, Diepgen TL, Handwerker HO,. Opiate and H1antagonist effects on histamine induced pruritus and allokinesis. Pain 1997; 73: 239-243. (Pubitemid 27491686)
7. Ikoma A, Rukwied R, Stander S, Steinhoff M, Miyachi Y, Schmelz M,. Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol 2003; 139: 1455-1458. (Pubitemid 37433135)
8. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP,. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305: 1212-1221. (Pubitemid 36618001)
9. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004; 142: 161-171. (Pubitemid 38698205)
10. Gutzmer R, Diestel C, Mommert S, Kother B, Stark H, Wittmann M, et al. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 2005; 174: 5224-5232. (Pubitemid 40593160)
11. Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL,. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 2006; 176: 7062-7070. (Pubitemid 43787887)
12. Hirasawa N, Ohsawa Y, Katoh G, Shibata K, Ishihara K, Seyama T, et al. Modification of the picryl chloride-induced allergic dermatitis model in mouse ear lobes by 12-O-tetradecanoylphorbol 13-acetate, and analysis of the role of histamine in the modified model. Int Arch Allergy Immunol 2009; 148: 279-288.
13. Cowden JM, Zhang M, Dunford PJ, Thurmond RL,. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 2010; 130: 1023-1033.
14. Cowden JM, Riley JP, Ma JY, Thurmond RL, Dunford PJ,. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res 2010; 11: 86.
15. Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C,. Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 2009; 9: 734-738.
16. Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL,. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007; 119: 176-183. (Pubitemid 46037799)
17. Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, et al. Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 2009; 18: 57-63.
18. Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H,. Histamine H(4) receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 2010; 65: 319-326.
19. Suwa E, Yamaura K, Oda M, Namiki T, Ueno K,. Histamine H(4) receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 2011; 667: 383-388.
20. Frosch PJ, Schwanitz HJ, Macher E,. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res 1984; 276: 36-40. (Pubitemid 14202294)
21. Tamura T, Amano T, Ohmori K, Manabe H,. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 2005; 524: 149-154. (Pubitemid 41606828)
22. Ishii H, Sasaki Y, Ikemura T, Kitamura S, Ohmori K,. Pharmacological studies on KW-4679, an antiallergic drug. (1): inhibitory effect on passive cutaneous anaphylaxis (PCA) and experimental asthma in rats and guinea pigs. Nihon Yakurigaku Zasshi 1995; 106: 289-298.
23. Greaves MW,. Antihistamines in dermatology. Skin Pharmacol Physiol 2005; 18: 220-229. (Pubitemid 41159953)
24. Herman SM, Vender RB,. Antihistamines in the treatment of dermatitis. J Cutan Med Surg 2003; 7: 467-473.
25. Thurmond RL, Gelfand EW, Dunford PJ,. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 2008; 7: 41-53.
26. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M,. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71-79. (Pubitemid 34779440)
27. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z,. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009; 53: 48-54.
28. Kanda N, Watanabe S,. Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol 2003; 121: 570-577. (Pubitemid 37072270)
29. Tominaga M, Ogawa H, Takamori K,. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 2008; 158: 842-844. (Pubitemid 351415719)
30. Murota H, El-latif MA, Tamura T, Amano T, Katayama I,. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice. Int Arch Allergy Immunol 2010; 153: 121-132.
31. Yamaura K, Oda M, Suwa E, Suzuki M, Sato H, Ueno K,. Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 2009; 34: 427-431.
32. Harada D, Takada C, Nosaka Y, Takashima Y, Kobayashi K, Takaba K, et al. Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models. Int Immunopharmacol 2009; 9: 55-62.
33. Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM,. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 1996; 278: 1252-1261. (Pubitemid 27166976)
34. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-541. (Pubitemid 32210037)
35. Morita E, Takahashi H, Niihara H, Dekio I, Sumikawa Y, Murakami Y, et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy 2010; 65: 1166-1172.